Brandywine Global Investment Management, LLC Exelixis, Inc. Transaction History

Brandywine Global Investment Management, LLC

$14.2 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$20.34 - $23.73 $1.08 Million - $1.26 Million	-52,927 Reduced 3.48%	1,467,748 $33 Million
Q1 2024 May 13, 2024	BUY	$20.17 - $23.93 $1.75 Million - $2.08 Million	86,760 Added 6.05%	1,520,675 $36.1 Million
Q4 2023 Feb 09, 2024	BUY	$19.25 - $24.13 $2.41 Million - $3.03 Million	125,368 Added 9.58%	1,433,915 $34.4 Million
Q3 2023 Nov 13, 2023	SELL	$19.04 - $22.74 $639,934 - $764,291	-33,610 Reduced 2.5%	1,308,547 $28.6 Million
Q2 2023 Aug 11, 2023	BUY	$18.17 - $20.48 $8.15 Million - $9.18 Million	448,309 Added 50.15%	1,342,157 $25.6 Million
Q1 2023 May 12, 2023	BUY	$16.3 - $19.41 $14.6 Million - $17.3 Million	893,848 New	893,848 $17.3 Million

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.19 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.04 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$905 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$547 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$408 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Account